BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 27528267)

  • 1. Hepatitis E Virus Mutations: Functional and Clinical Relevance.
    van Tong H; Hoan NX; Wang B; Wedemeyer H; Bock CT; Velavan TP
    EBioMedicine; 2016 Sep; 11():31-42. PubMed ID: 27528267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin Treatment Failure-Associated Mutation, Y1320H, in the RNA-Dependent RNA Polymerase of Genotype 3 Hepatitis E Virus (HEV) Enhances Virus Replication in a Rabbit HEV Infection Model.
    Wang B; Mahsoub HM; Li W; Heffron CL; Tian D; Hassebroek AM; LeRoith T; Meng XJ
    mBio; 2023 Apr; 14(2):e0337222. PubMed ID: 36809085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Hepatitis E Virus Biology and Pathogenesis.
    Lin S; Zhang YJ
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis E virus. Advances in HEV biology and HEV vaccine approaches.
    Yarbough PO
    Intervirology; 1999; 42(2-3):179-84. PubMed ID: 10516473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making the case for the development of a vaccination against hepatitis E virus.
    Haffar S; Bazerbachi F; Lake JR
    Liver Int; 2015 Feb; 35(2):311-6. PubMed ID: 24836400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
    Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
    J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E: latest developments in knowledge.
    Pérez-Gracia MT; Suay-García B; García M; Mateos-Lindemann ML
    Future Microbiol; 2016 Jun; 11():789-808. PubMed ID: 27203841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of functional cis-acting RNA elements in the hepatitis E virus genome required for viral replication.
    Ju X; Xiang G; Gong M; Yang R; Qin J; Li Y; Nan Y; Yang Y; Zhang QC; Ding Q
    PLoS Pathog; 2020 May; 16(5):e1008488. PubMed ID: 32433693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis E virus.
    Panda SK; Thakral D; Rehman S
    Rev Med Virol; 2007; 17(3):151-80. PubMed ID: 17051624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E virus.
    Abravanel F; Lhomme S; Dubois M; Peron JM; Alric L; Kamar N; Izopet J
    Med Mal Infect; 2013 Jul; 43(7):263-70. PubMed ID: 23608595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122.
    Haldipur B; Bhukya PL; Arankalle V; Lole K
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29540601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous Nuclear Ribonucleoproteins Participate in Hepatitis E Virus Replication.
    Pingale KD; Kanade GD; Karpe YA
    J Mol Biol; 2020 Mar; 432(7):2369-2387. PubMed ID: 32119874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis E Virus Assembly and Release.
    Ju X; Ding Q
    Viruses; 2019 Jun; 11(6):. PubMed ID: 31181848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat Hepatitis E Virus as Cause of Persistent Hepatitis after Liver Transplant.
    Sridhar S; Yip CCY; Wu S; Cai J; Zhang AJ; Leung KH; Chung TWH; Chan JFW; Chan WM; Teng JLL; Au-Yeung RKH; Cheng VCC; Chen H; Lau SKP; Woo PCY; Xia NS; Lo CM; Yuen KY
    Emerg Infect Dis; 2018 Dec; 24(12):2241-2250. PubMed ID: 30457530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
    Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis E virus treatment and ribavirin therapy: viral mechanisms of nonresponse.
    Todt D; Meister TL; Steinmann E
    Curr Opin Virol; 2018 Oct; 32():80-87. PubMed ID: 30384328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E, the neglected one.
    Blasco-Perrin H; Abravanel F; Blasco-Baque V; Péron JM
    Liver Int; 2016 Jan; 36 Suppl 1():130-4. PubMed ID: 26725910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in hepatitis E - II: Epidemiology, clinical manifestations, treatment and prevention.
    Goel A; Aggarwal R
    Expert Rev Gastroenterol Hepatol; 2016 Sep; 10(9):1065-74. PubMed ID: 27148907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.